How Can Medtechs Prepare for the FDA’s Shift Left Strategy on Cybersecurity

The recent FDA guidance on security marks good and bad news for the industry. In short, the FDA can now refuse submissions from medical device manufacturers if they can’t demonstrate that they have comprehensive cybersecurity processes and detailed information on the composition of their…
Source: medcitynews.com – Read more